The role of mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modelling in translational research of biologics-Reference-Cited by-同舟云学术

The role of mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) modelling in translational research of biologics

Published:2007-12 Issue:23-24 Volume:12 Page:1018-1024
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Agoram Balaji M.,Martin Steven W.,van der Graaf Piet H.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference59 articles.

1. Pharmacokinetic–pharmacodynamic modelling: history and perspectives;Csajka;J. Pharmacokinet. Pharmacodyn.,2006

2. Modelling and simulation in clinical drug development;Rooney;Drug Discov. Today,2001

3. Pharmacokinetic/pharmacodynamic modeling in drug development;Sheiner;Annu. Rev. Pharmacol. Toxicol.,2000

4. Role of modelling and simulation in Phase I drug development;Aarons;Eur. J. Pharm. Sci.,2001

5. Mechanism-based pharmacokinetic–pharmacodynamic modeling for the prediction of in vivo drug concentration–effect relationships – Application in drug candidate selection and lead optimization;Danhof,2007

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can we do better with Mylotarg? Model-based assessment of opportunities to improve therapeutic index;Toxicology and Applied Pharmacology;2024-09

2. Monoclonal Antibodies: From Structure to Therapeutic Application;Pharmaceutical Biotechnology;2024

3. Pharmacometrics: Application in Drug Development and Clinical Practice;Asian Journal of Pharmaceutical Analysis;2023-09-07

4. Machine-learning-based adverse drug event prediction from observational health data: A review;Drug Discovery Today;2023-09

5. A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic‐Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development;Clinical Pharmacology & Therapeutics;2023-06-02